Nutrien (NTR) Expected to Announce Earnings on Wednesday

Nutrien (NYSE:NTRGet Free Report) is anticipated to post its Q4 2025 results after the market closes on Wednesday, February 18th. Analysts expect the company to announce earnings of $0.87 per share and revenue of $5.2619 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 19, 2026 at 10:00 AM ET.

Nutrien Price Performance

Shares of NYSE NTR opened at $71.06 on Wednesday. The firm has a market cap of $34.25 billion, a P/E ratio of 19.15 and a beta of 0.73. Nutrien has a 52 week low of $45.78 and a 52 week high of $73.07. The business’s 50 day moving average price is $64.49 and its 200 day moving average price is $60.02. The company has a quick ratio of 0.89, a current ratio of 1.41 and a debt-to-equity ratio of 0.39.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Wall Street Zen raised shares of Nutrien from a “hold” rating to a “buy” rating in a research note on Saturday, January 31st. Royal Bank Of Canada boosted their price target on Nutrien from $70.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 20th. Oppenheimer reaffirmed an “outperform” rating on shares of Nutrien in a research note on Tuesday, January 27th. Mizuho upped their target price on Nutrien from $65.00 to $68.00 and gave the company a “neutral” rating in a report on Friday, January 16th. Finally, Wells Fargo & Company started coverage on shares of Nutrien in a report on Tuesday, November 11th. They set an “equal weight” rating and a $64.00 price target for the company. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $66.31.

Read Our Latest Research Report on NTR

Institutional Trading of Nutrien

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Nutrien by 65.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,224 shares of the company’s stock valued at $1,253,000 after acquiring an additional 9,950 shares in the last quarter. NewEdge Advisors LLC boosted its stake in shares of Nutrien by 6.2% during the 1st quarter. NewEdge Advisors LLC now owns 6,907 shares of the company’s stock worth $343,000 after acquiring an additional 404 shares in the last quarter. Focus Partners Wealth purchased a new position in Nutrien in the 1st quarter valued at approximately $516,000. Acadian Asset Management LLC acquired a new position in Nutrien during the first quarter worth $54,000. Finally, Prudential Financial Inc. purchased a new stake in Nutrien during the second quarter worth $203,000. 63.10% of the stock is owned by hedge funds and other institutional investors.

About Nutrien

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

See Also

Earnings History for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.